Australia Cbd Oil & Cbd Consumer Health Market Size & Outlook
- Cannabis
- Cannabidiol & Cannabinoids
- CBD Oil & CBD Consumer Health Market Outlook
- Cannabidiol & Cannabinoids
Australia Cbd Oil Cbd Consumer Health Market, 2018-2030 (US$M)
Global Market
Related Markets
Ask Prism AI anything about the cbd oil & cbd consumer health market
Get a cited answer from GVR research in seconds: segment shares, growth drivers, regulation and forecast assumptions.
Australia cbd oil & cbd consumer health market highlights
- The Australia cbd oil & cbd consumer health market generated a revenue of USD 57.1 million in 2024 and is expected to reach USD 606.0 million by 2030.
- The Australia market is expected to grow at a CAGR of 48.2% from 2025 to 2030.
- In terms of segment, cbd infused skincare products was the largest revenue generating product in 2024.
- CBD Infused Beauty Products is the most lucrative product segment registering the fastest growth during the forecast period.
Cbd oil & cbd consumer health market data book summary
| Market revenue in 2024 | USD 57.1 million |
| Market revenue in 2030 | USD 606.0 million |
| Growth rate | 48.2% (CAGR from 2025 to 2030) |
| Largest segment | Cbd infused skincare products |
| Fastest growing segment | CBD Infused Beauty Products |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | CBD Infused Skincare Products, CBD Infused Beauty Products, CBD Infused Haircare Products |
Other key industry trends
- In terms of revenue, Australia accounted for 1.4% of the global cbd oil & cbd consumer health market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China cbd oil & cbd consumer health market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 571.8 million by 2030.
Since the legalization of medical cannabis in Australia in 2016, the number of patients seeking prescription for medical cannabis and its derived products has increased tremendously. The number of companies operating in medical cannabis market is also rising, with new companies being listed on the Australian Stock Exchange (ASX).
Several local companies have begun applying for cultivation license and are being funded or acquired by major players. However, Australian CBD market is expected to witness slower growth as compared to North America, mainly due to stringent regulatory guidelines for prescribing medical cannabis (oils and tinctures) as a therapeutic product in Australia.
Currently, accessing medical CBD oil in the country is complicated and expensive as no CBD product has been approved by Therapeutic Goods Administration (TGA)—the regulatory body for therapeutic goods in Australia. Hence, patients who want to use CBD-based products need to apply for Australian government’s Special Access Scheme that provides CBD- and THC-infused products to qualifying patients. These factors are restraining the CBD market growth in the country.
No credit card required*
Publish Date: Apr 03, 2025
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
CBD Oil & CBD Consumer Health Market Scope
CBD Oil CBD Consumer Health Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Aurora Cannabis Inc | View profile | 1,130 | 3498 63 Avenue, Leduc, AB, Canada, T9E 0G8 | www.auroramj.com |
| Charlottes Web Holdings Inc Ordinary Shares | View profile | 164 | 700 Tech Court, Louisville, CO, United States, 80027 | www.charlottesweb.com |
| Medical Marijuana Inc | View profile | 85 | 2384 La Mirada Drive, Vista, CA, United States, 92081 | www.medicalmarijuanainc.com |
| Joy Organics | View profile | 11-50 | Fort Collins, Colorado, United States, North America | joyorganics.com |
| Elixinol Wellness Ltd Ordinary Shares | View profile | - | 680 George Street, Level 12, Sydney, NSW, Australia, 2000 | www.elixinolwellness.com |
| Isodiol International Inc | View profile | 197 | 200 Granville Street, Suite 2710, Vancouver, BC, Canada, V6C 1S4 | www.isodiol.com |
| Endoca | View profile | 1-10 | Hoofddorp, Noord-Holland, The Netherlands, Europe | www.endoca.com/pl |
| NuLeaf Naturals | View profile | 51-100 | Denver, Colorado, United States, North America | nuleafnaturals.com/ |
| Canopy Growth Corporation | View profile | - | - | - |
| Kazmira | View profile | 101-250 | Watkins, Colorado, United States, North America | www.kazmira-llc.com |
Australia CBD Oil & CBD Consumer Health Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to CBD Oil & CBD Consumer Health Market Outlook will help companies and investors design strategic landscapes.
Cbd Infused Skincare Products was the largest segment with a revenue share of 58.49% in 2024.
Horizon Databook has segmented the Australia cbd oil & cbd consumer health market based on cbd infused skincare products, cbd infused beauty products, cbd infused haircare products covering the revenue growth of each sub-segment from 2018 to 2030.
Since the legalization of medical cannabis in Australia in 2016, the number of patients seeking prescription for medical cannabis and its derived products has increased tremendously. The number of companies operating in medical cannabis market is also rising, with new companies being listed on the Australian Stock Exchange (ASX).
Several local companies have begun applying for cultivation license and are being funded or acquired by major players. However, Australian CBD market is expected to witness slower growth as compared to North America, mainly due to stringent regulatory guidelines for prescribing medical cannabis (oils and tinctures) as a therapeutic product in Australia.
Currently, accessing medical CBD oil in the country is complicated and expensive as no CBD product has been approved by Therapeutic Goods Administration (TGA)—the regulatory body for therapeutic goods in Australia. Hence, patients who want to use CBD-based products need to apply for Australian government’s Special Access Scheme that provides CBD- and THC-infused products to qualifying patients. These factors are restraining the CBD market growth in the country.
- Australia Cbd Oil & Cbd Consumer Health Market Product Outlook (Revenue, USD Million , 2018-2030)
- CBD Infused Skincare Products
- CBD Infused Beauty Products
- CBD Infused Haircare Products
Reasons to subscribe to CBD Oil & CBD Consumer Health Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of CBD Oil & CBD Consumer Health Market Outlook databook
- Our clientele includes a mix of CBD Oil & CBD Consumer Health Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia CBD Oil & CBD Consumer Health Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Australia CBD Oil & CBD Consumer Health Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Australia Cbd Oil Cbd Consumer Health Market, 2018-2030 (US$M)
Australia Product - Cbd Oil & Cbd Consumer Health Market Statistics, 2024 - 2030 (US$M)
